Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Penetrance is the proportion of individuals with a specific gene variant who actually show the related trait or disease. When the proportion is 100%, penetrance is complete; anything less is incomplete. Many ocular conditions show incomplete penetrance, which explains why a mutation may run in a family yet spare some relatives. Environment, modifier genes, and age all influence expression.
read more about penetrance ...Diet, sunlight exposure, concurrent illnesses, and background genetics can raise or lower expression. Some traits appear only after a certain age, making penetrance look lower in youth. Screening may reveal subtle signs in relatives once thought unaffected. Understanding these factors guides counseling.
Many traits depend on a mix of genes and environment. When both change, expression shifts across generations. Early screening brings mild or hidden cases to light. These insights help families plan and interpret risk more accurately.
Examples include some forms of congenital glaucoma, retinitis pigmentosa variants, and optic nerve anomalies. Even within one family, findings can range from mild to severe. Genetic testing clarifies risk but cannot predict exact timing. Regular exams help catch early changes.
Penetrance asks whether the trait appears at all, while expressivity describes how strong or varied the features are. A trait can have high penetrance but wide expressivity. Both ideas help explain family patterns. Counselors use them to set expectations.
Apparent penetrance can rise as relatives age or as tests improve. Lifestyle shifts may also change risk. Longitudinal studies refine estimates for specific genes. Families benefit from periodic updates.
Does high penetrance mean severe disease? Not necessarily; it only reflects the chance of showing any features.
Can penetrance be zero? If no carriers show the trait, the variant may be benign.
Should carriers be treated? Management is tailored to signs, risk level, and preferences.
“Penetrance.” Genomics Education Programme (NHS England). https://www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/penetrance/. Reviewed April 14, 2025
“What are reduced penetrance and variable expressivity?” MedlinePlus Genetics (U.S. National Library of Medicine). https://medlineplus.gov/genetics/understanding/inheritance/penetranceexpressivity/. Published November 16, 2021
“Genetics, Autosomal Dominant.” StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK539844/. Updated May 1, 2023
“The fundamentals of eye tracking part 4: Tools for conducting eye tracking research.” Niehorster DC, et al. Behavior Research Methods (Springer). https://link.springer.com/article/10.3758/s13428-024-02529-7. Published 2025
“The fundamentals of eye tracking part 1.” Hessels RS, et al. (PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC11638287/. Published 2024